In Europe, meanwhile, Regeneron’s PD-1 inhibitor Libtayo (cemiplimab) is indicated as a second-line therapy for recurrent or advanced cervical cancer, regardless of PD-L1 expression status, ...

either with or after chemoradiotherapy as a first-line therapy for women with locally-advanced cervical cancer Sanofi/Regeneron are going after the second-line population with their drug Libtayo ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

He expressed concern that every year in Nigeria, more than 12,000 women suffer from cervical cancer, saying the disease is preventable. Prof. Pate noted that President Bola Tinubu was committed to ...

Launched in 2023 to prevent cervical cancer, India’s first indigenous human papilloma virus (HPV) vaccine—Cervavac—has found only 63 takers in the 18-25 age group at the Post Graduate ...

PETALING JAYA: Cervical cancer is ranked as the fourth most common cancer affecting women in Malaysia, with 1,740 cases in 2020 of whom 991 or 57% succumbed to the disease, according to the Global ...

First Lady Oluremi Tinubu’s Renewed Hope Initiative (RHI) has announced a N1 billion donation to the fight against cervical cancer by the National Cancer Fund. The donation, which coincided with ...

For many reasons, including sensitivity and stigma surrounding the locations of these cancers, gynaecological cancers are ...

Experts are warning against overusing these common cooking oils because they contain a fat that is reportedly linked to breast cancer. Seed and vegetable oils don’t have the best reputation ...

Although Malaysia’s on-going efforts against cervical cancer were temporarily derailed by Covid-19 lockdowns, Dr Murallitharan said there is a strong commitment to get them back on track and ...